Related Experiment Video
Updated: Aug 1, 2026

Utilizing the Antigen Capsid-Incorporation Strategy for the Development of Adenovirus Serotype 5-Vectored Vaccine Approaches
Published on: May 6, 2015
Comparison of the immunogenicity and reactogenicity of two commercially available hexavalent vaccines administered as
I Tichmann1, H Preidel, D Grunert
1Arztpraxis München, Germany.
Insights
Infanrix hexa demonstrated superior immunogenicity for the hepatitis B vaccine component compared to Hexavac in infants. Antibody responses to diphtheria and polio were also higher with Infanrix hexa, with similar safety profiles.
Area of Science:
- Pediatric Vaccinology
- Immunology
- Public Health
Background:
- Infant vaccination schedules are critical for establishing early immunity against serious diseases.
- Comparative studies are essential to evaluate the efficacy and safety of different vaccine formulations.
Purpose of the Study:
- To compare the immunogenicity and safety of Infanrix hexa versus Hexavac vaccines in infants.
- To assess antibody responses to hepatitis B, diphtheria, polio, tetanus, Hib, and pertussis components.
Main Methods:
- A randomized trial involving 459 infants receiving either Infanrix hexa or Hexavac at 2, 4, and 6 months.
- Immunogenicity assessed via seroprotection rates and Geometric Mean Concentrations (GMCs) for hepatitis B.
- Antibody levels measured for diphtheria, polio, tetanus, Hib, and pertussis components.
Main Results:
- Infanrix hexa showed statistically significantly higher hepatitis B seroprotection (98.6% vs 94.7%) and GMCs (905.6 vs 226.4).
- Significantly higher antibody levels against diphtheria and polio were observed with Infanrix hexa (p < 0.0001).
- Comparable immune responses were noted for tetanus, Hib, and pertussis components; low adverse event rates in both groups.
Conclusions:
- Infanrix hexa offers superior immunogenicity for its hepatitis B component compared to Hexavac in infants.
- Infanrix hexa also induces higher antibody levels for diphtheria and polio antigens.
- Both vaccines exhibited favorable safety profiles, with low incidences of adverse events.
Abstract:
Infants (N = 459) were randomly assigned to receive either Infanrix hexa or Hexavac vaccines at 2, 4 and 6 months of age as a primary vaccination schedule. The immunogenicity of the hepatitis B component was statistically significantly higher for Infanrix hexa compared to Hexavac in terms of both seroprotection (98.6% versus 94.7%, p = 0.0302) and GMCs (905.6 versus 226.4, p < 0.0001). Significantly (p < or =0.0001) higher antibody levels against diphtheria and the 3 polio components were also induced by Infanrix hexa. The responses to tetanus, Hib and pertussis components were similar. The incidences of clinically relevant solicited symptoms, unsolicited symptoms or serious adverse events were low in both groups.
Related Concept Videos
Cross-reactivity
Vaccinations
Antigens Involved in Adaptive Immunity
Complete Antigens
Complete antigens possess both immunogenicity and reactivity.
Immunological Memory
What is Immunological Memory?
Immunological memory is an integral function of the immune system that allows it to recognize and react more rapidly and effectively to pathogens previously encountered. This feature is...
Development of Immunocompetence
The initial cells that migrate from the fetal thymus settle within the skin and epithelial tissues lining the mouth, digestive tract, and in females, the uterus and vagina. These cells, including skin-based dendritic cells, serve as antigen-presenting cells, playing a key role in T cell activation.
Subsequent T...
Vaccines

